{
  "id": "30ee01319f7bbe4c",
  "title": "FDA Approves Nufymco , Interchangeable Ranibizumab Biosimilar , for Retinal Diseases",
  "description": "20251223T203000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-approves-nufymco-interchangeable-ranibizumab-biosimilar-for-retinal-diseases",
  "published_at": "20251223T203000Z",
  "fetched_at": "2025-12-24T00:22:47.431682+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-approves-nufymco-interchangeable-ranibizumab-biosimilar-for-retinal-diseases",
    "url_mobile": "",
    "title": "FDA Approves Nufymco , Interchangeable Ranibizumab Biosimilar , for Retinal Diseases",
    "seendate": "20251223T203000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/39b3a2e9338881f9ad7e1f3258ec868d2e8fd75e-3000x3186.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}